530 related articles for article (PubMed ID: 7686496)
1. Modulation of human endothelial cell activation by antiproliferative cytokines: exploration of arachidonic acid and intracellular cytokine pathways as possible mechanisms of action.
Delomenie C; Wautier-Pepin MP; Chappey O; Wautier JL
Exp Cell Res; 1993 Jul; 207(1):122-30. PubMed ID: 7686496
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma enhances endothelial activation induced by tumor necrosis factor but not IL-1.
Doukas J; Pober JS
J Immunol; 1990 Sep; 145(6):1727-33. PubMed ID: 1697308
[TBL] [Abstract][Full Text] [Related]
3. Monocyte modulation of endothelial leukocyte adhesion molecules.
Weill D; Wautier JL; Dosquet C; Wautier MP; Carreno MP; Boval B
J Lab Clin Med; 1995 Jun; 125(6):768-74. PubMed ID: 7539477
[TBL] [Abstract][Full Text] [Related]
4. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma.
Thornhill MH; Haskard DO
J Immunol; 1990 Aug; 145(3):865-72. PubMed ID: 1695647
[TBL] [Abstract][Full Text] [Related]
5. Effect of human cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-4) on porcine endothelial cells: induction of MHC and adhesion molecules and functional significance of these changes.
Batten P; Yacoub MH; Rose ML
Immunology; 1996 Jan; 87(1):127-33. PubMed ID: 8666424
[TBL] [Abstract][Full Text] [Related]
6. ICAM-1-independent lymphocyte transmigration across high endothelium: differential up-regulation by interferon gamma, tumor necrosis factor-alpha and interleukin 1 beta.
May MJ; Ager A
Eur J Immunol; 1992 Jan; 22(1):219-26. PubMed ID: 1346111
[TBL] [Abstract][Full Text] [Related]
7. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells.
Pang L; Knox AJ
Br J Pharmacol; 1997 Jun; 121(3):579-87. PubMed ID: 9179403
[TBL] [Abstract][Full Text] [Related]
8. Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin 1 alpha, interleukin 1 beta, and tumor necrosis factor.
Beresini MH; Lempert MJ; Epstein LB
J Immunol; 1988 Jan; 140(2):485-93. PubMed ID: 3121746
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
10. The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-alpha and IL-1.
Sikorski EE; Hallmann R; Berg EL; Butcher EC
J Immunol; 1993 Nov; 151(10):5239-50. PubMed ID: 7693807
[TBL] [Abstract][Full Text] [Related]
11. Cytokine activation of human macro- and microvessel-derived endothelial cells.
Gerritsen ME; Niedbala MJ; Szczepanski A; Carley WW
Blood Cells; 1993; 19(2):325-39; discussion 340-2. PubMed ID: 7906155
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium.
Smith WB; Noack L; Khew-Goodall Y; Isenmann S; Vadas MA; Gamble JR
J Immunol; 1996 Jul; 157(1):360-8. PubMed ID: 8683138
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of basal and tumor necrosis factor-enhanced binding of murine tumor cells to murine endothelium by transforming growth factor-beta 1.
Bereta J; Bereta M; Coffman FD; Cohen S; Cohen MC
J Immunol; 1992 May; 148(9):2932-40. PubMed ID: 1315361
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
Belizario JE; Dinarello CA
Cancer Res; 1991 May; 51(9):2379-85. PubMed ID: 2015601
[TBL] [Abstract][Full Text] [Related]
15. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 alpha inhibits the effects of gamma-interferon and tumor necrosis factor alpha on the expression of the major histocompatibility antigens by the rat endothelium.
Leszczynski D
Am J Pathol; 1990 Jan; 136(1):229-37. PubMed ID: 2105059
[TBL] [Abstract][Full Text] [Related]
17. Induction of chemokine mRNA in bone marrow stromal cells: modulation by TGF-beta 1 and IL-4.
Gautam SC; Noth CJ; Janakiraman N; Pindolia KR; Chapman RA
Exp Hematol; 1995 Jun; 23(6):482-91. PubMed ID: 7768303
[TBL] [Abstract][Full Text] [Related]
18. Thrombin enhances monocyte secretion of tumor necrosis factor and interleukin-1 beta by two distinct mechanisms.
Hoffman M; Cooper ST
Blood Cells Mol Dis; 1995; 21(2):156-67. PubMed ID: 8846045
[TBL] [Abstract][Full Text] [Related]
19. Regulation of rat pulmonary artery endothelial cell transforming growth factor-beta production by IL-1 beta and tumor necrosis factor-alpha.
Phan SH; Gharaee-Kermani M; McGarry B; Kunkel SL; Wolber FW
J Immunol; 1992 Jul; 149(1):103-6. PubMed ID: 1376744
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes.
Vaday GG; Schor H; Rahat MA; Lahat N; Lider O
J Leukoc Biol; 2001 Apr; 69(4):613-21. PubMed ID: 11310848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
